The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for

Company welcomes additional recycling technology to its portfolio A group of employees stands inside APK AG’s factory in Merseburg, Germany, now part of LyondellBasell Ambition to further develop solvent-based recycling technology and bring to commercial scale Company secures future of

Some regions in US to see 15% electricity demand growth through 2029; prices could escalate 2024-29 GWh demand growth as a percentage of 2024 GWh demand LONDON and HOUSTON and SINGAPORE, Oct. 17, 2024 (GLOBE NEWSWIRE) — US power demand

DURHAM, N.C., Oct. 17, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the release of the company’s inaugural Corporate Social Responsibility report, “Fortrea for Better.” Available for download on Fortrea.com, the report